These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28950684)

  • 1. Deregulation of miR-34a and Its Chaperon Hsp70 in Hepatitis C virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma Patients.
    Shehata RH; Abdelmoneim SS; Osman OA; Hasanain AF; Osama A; Abdelmoneim SS; Toraih EA
    Asian Pac J Cancer Prev; 2017 Sep; 18(9):2395-2401. PubMed ID: 28950684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma.
    Chen S; Mao Y; Chen W; Liu C; Wu H; Zhang J; Wang S; Wang C; Lin Y; Lv Y
    J Cancer; 2022; 13(5):1410-1417. PubMed ID: 35371309
    [No Abstract]   [Full Text] [Related]  

  • 6. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Gehrmann M; Cervello M; Montalto G; Cappello F; Gulino A; Knape C; Specht HM; Multhoff G
    Front Immunol; 2014; 5():307. PubMed ID: 25071768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C
    Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
    Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z
    Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
    Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.
    Yacoub RA; Fawzy IO; Assal RA; Hosny KA; Zekri AN; Esmat G; El Tayebi HM; Abdelaziz AI
    J Clin Transl Hepatol; 2016 Dec; 4(4):300-305. PubMed ID: 28097098
    [No Abstract]   [Full Text] [Related]  

  • 15. Retracted: MicroRNA-34a inhibit hepatocellular carcinoma progression by repressing hexokinase-1.
    Zhou Y; Liu K; Liu Y; Tan L
    J Cell Biochem; 2019 May; 120(5):7147-7153. PubMed ID: 30474301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating
    Han R; Chen X; Li Y; Zhang S; Li R; Lu L
    Cancer Manag Res; 2019; 11():2963-2976. PubMed ID: 31114344
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.
    Bharali D; Banerjee BD; Bharadwaj M; Husain SA; Kar P
    J Clin Exp Hepatol; 2019; 9(3):294-301. PubMed ID: 31360021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.